🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07310667
Enrolling by invitation Observational

Assessing the Relationship Between Frailty and Skeletal Muscle Thickness in Critically Ill Patients

NCT07310667 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-05-02
Last updated
2026-03-19

Condition(s) studied

FrailityNutrition AssessmentUltrasound EvaluationCritical Illness

Investigational drug(s) / intervention(s)

Muscle ultrasound

Muscle ultrasound: Examine all patients both USG and Fraility scale

Study summary

Assessment of muscle mass in critically ill patients is critical for both improving clinical outcomes and monitoring the effectiveness of nutritional interventions. Loss of muscle mass is associated with mortality and morbidity in the elderly, including organ transplantation, trauma, and sepsis. Previous studies have assessed muscle mass using computed tomography. The use of computed tomography is costly, carries radiation risks, and requires the patient to be transported to a CT scanner. In contrast, ultrasonography is a noninvasive, rapid, and bedside method without radiation exposure. In particular, anterior thigh muscle thickness (ATMT) stands out as a reliable biomarker in the assessment of muscle mass. ATMT measurement includes the assessment of the combined depth of the vastus intermedius and rectus femoris muscles in the anterior thigh. There is no study in the literature examining the effects of anterior thigh muscle thickness measured by ultrasonography on malnutrition and frailty in intensive care patients. In this study, we aimed to investigate the effects of anterior thigh muscle thickness on frailty, malnutrition and length of stay in intensive care patients.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * over 65 * 1 week min stay Exclusion Criteria: * Patients under 65 years of age * those with cardiac arrest, terminal illnesses, advanced cancer, advanced neurodegenerative diseases, * those with knee or hip prosthesis that would affect the anterior thigh muscle thickness measurement those whose intensive care stay did not exceed 1 week will be excluded.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara Training And Research Hospital Altındağ Ankara

More Ankara Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07310667 on ClinicalTrials.gov ↗ ← All trials in Turkey